Skip to main content
. 2022 Sep;21(4):32–52.

Table S7.

DHEA Modulation of Vaccine Efficacy

Dosage Timing (before/after vaccination) Control Population Vaccine Type Outcome Citation
DHEA 50 mg BID DHEAS (oral) 100mg total daily dosage 4 days, starting 2 days prior to vaccination 50 mg corn starch BID Total daily dose 100mg Males 65+ years
n=66
Tetanus booster No significant change in vaccine responsea Araneo et al63
DHEA 50 mg BID DHEA (oral) 100mg total daily dosage 4 days, starting 2 days prior to vaccination Not specified 61-89 years
n=71
TIV No significant change in vaccine responsea Possible negative effect on vaccine response in individuals without baseline protective antibody titers. Danenberg et al64
DHEA 7.5 mg subcutaneous DHEAS Single dose concurrent to vaccination Vaccination only 73-90 years
n=78
Control group consisted of adults <40 years
TIV Significantly improved serological protection for H3N2 in those with low pre-vaccination titers and lower DHEAS levels, but not other strainsb Degelau et al65

aNo significant effect on/association with vaccine response

bSignificant effect on/association with vaccine response for at least one vaccine strain/subgroup